In small cell lung cancer and leukemia cells, Sig1R agonists cause the accumulation of p27Kip1 and a decrease in cyclin A (negative and positive influencers of G1/S transition respectively) [43], partly through functional inhibition of voltage‐regulated K+ channels [44]. Here, SIGMAR1 is linked to small cell lung carcinoma.